Target Name: CAMKMT
NCBI ID: G79823
Review Report on CAMKMT Target / Biomarker Content of Review Report on CAMKMT Target / Biomarker
CAMKMT
Other Name(s): Calmodulin-lysine N-methyltransferase | C2orf34 | CaM KMT | Cam | calmodulin-lysine N-methyltransferase | FLJ23451 | CMKMT_HUMAN | KMT | CLNMT | OTTHUMP00000158959 | Uncharacterized protein C2orf34

CAMKMT Gene Involved in Neurotransmitter Synthesis and CNS Function

CAMKMT (Calmodulin-lysine N-methyltransferase) is a gene that encodes a protein involved in the neurotransmitter synthesis and release process in the central nervous system (CNS). The CAMKMT gene has been implicated in the development and progression of various neurological disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia.

The neurotransmitter systems in the CNS are critical for the proper functioning of the brain, and the dysregulation of these systems has been implicated in the development of many neurological disorders. The neurotransmitter synthesis and release process is a critical step in this process, and the CAMKMT protein plays a crucial role in this process.

The CAMKMT gene is located on chromosome 11q22 and has been implicated in the development and progression of various neurological disorders. Studies have shown that individuals with certain genetic variations in the CAMKMT gene are at increased risk for developing these disorders. For example, individuals with the APTN3520T variant are at an increased risk of developing Alzheimer's disease, while individuals with the missenint variant are at an increased risk of developing Parkinson's disease.

In addition to its involvement in the neurotransmitter synthesis and release process, the CAMKMT protein has also been shown to play a role in the regulation of neurotransmitter signaling. The CAMKMT protein has been shown to interact with several neurotransmitter receptors, including dopamine, serotonin, and GABA. These interactions are important for the proper functioning of neurotransmitter signaling and are likely involved in the development and progression of various neurological disorders.

The CAMKMT gene has also been shown to be involved in the regulation of neurotransmitter synthesis and release in the peripheral nervous system (PNS). The PNS is responsible for the production and release of neurotransmitters, and the CAMKMT protein has been shown to play a role in this process.

In conclusion, the CAMKMT gene is involved in the neurotransmitter synthesis and release process in the CNS and has been implicated in the development and progression of various neurological disorders. The CAMKMT protein has also been shown to play a role in the regulation of neurotransmitter signaling and the regulation of neurotransmitter synthesis and release in the PNS. Further research is needed to fully understand the role of the CAMKMT gene in the development and progression of neurological disorders.

Protein Name: Calmodulin-lysine N-methyltransferase

Functions: Catalyzes the trimethylation of 'Lys-116' in calmodulin

The "CAMKMT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CAMKMT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CAMKV | CAMLG | CAMP | cAMP Phosphodiesterase | cAMP Responsive Element Binding Protein (CREB) | cAMP-Dependent protein kinase (PKA) | CAMSAP1 | CAMSAP2 | CAMSAP3 | CAMTA1 | CAMTA2 | CAND1 | CAND1.11 | CAND2 | Cannabinoid receptor | CANT1 | CANX | Cap-binding complex | CAP1 | CAP2 | CAPG | CAPN1 | CAPN10 | CAPN10-DT | CAPN11 | CAPN12 | CAPN13 | CAPN14 | CAPN15 | CAPN2 | CAPN3 | CAPN5 | CAPN6 | CAPN7 | CAPN8 | CAPN9 | CAPNS1 | CAPNS2 | CAPRIN1 | CAPRIN2 | CAPS | CAPS2 | CAPSL | CAPZA1 | CAPZA2 | CAPZA3 | CAPZB | Carbonic Anhydrase | Carbonic Anhydrase V | Carboxylesterase | Carboxypeptidase A | Carboxypeptidase B | Carboxypeptidase N | Carcinoembryonic Antigen-Related Cell Adhesion Molecule (CEA) | CARD10 | CARD11 | CARD14 | CARD16 | CARD17P | CARD18 | CARD19 | CARD6 | CARD8 | CARD8-AS1 | CARD9 | Cardiac Troponin | CARF | CARHSP1 | CARM1 | CARMAL | CARMIL1 | CARMIL2 | CARMIL3 | CARMN | Carnitine O-Palmitoyltransferase (CPT) | Carnitine O-Palmitoyltransferase 1 (CPT-1) | Carnitine O-palmitoyltransferase 2 | CARNMT1 | CARNS1 | CARS1 | CARS1-AS1 | CARS2 | CARTPT | CASC11 | CASC15 | CASC16 | CASC17 | CASC18 | CASC19 | CASC2 | CASC20 | CASC21 | CASC22 | CASC3 | CASC6 | CASC8 | CASC9 | CASD1 | Casein Kinase | Casein kinase I